(PDF) Autologous Matrix-induced Chondrogenesis Market: View Uses, Side Effects and Medicines | Detailed Study by Coherent Market Insights with Upcoming Trends
Autologous matrix-induced chondrogenesis is a novel treatment for repairing the damage of articular cartilage. This is a single step process which makes use of the microfracturing method, followed by bilayer collagen I/III membrane application with the help of a fibrin glue which is partially autologous. Joint and bone disorders including arthritis and osteoporosis being increasingly prevalent, rising injuries related to sports, along with increasing minimally-invasive surgery demand is driving growth of the global autologous matrix-induced chondrogenesis market.
Get Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/2748
Global Autologous Matrix-induced Chondrogenesis Market: Drivers
Increasing number of bone and joint disorders including arthritis and osteoporosis worldwide is expected to propel growth of the global autologous matrix-induced chondrogenesis market over the forecast period. For instance, as per the 2016 report from, National Center for Biotechnology Information (NCBI), around 200 million individuals suffered from osteoporosis globally, in 2015. Around 33% women of age 50 years and above and around 20% men are likely to suffer from osteoporosis fractures, within their lifetime.
Increasing prevalence of surgeries is expected to accelerate growth of the global autologous matrix-induced chondrogenesis market, over the forecast period. For instance, as per the 2019 report from American Academy of Orthopaedic Surgeon (AAOS), over 267,000 knee replacement surgeries are performed in the U.S. annually.
Tailored Information as per niche requirement:
LIMITED TIME OFFER - Hurry Up!
Exclusive offer!!! Purchase the report at a discounted rate!!!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/2748
Global Autologous Matrix-induced Chondrogenesis Market: Restraints
Inefficient reimbursement system along with high cartilage replacement costs are key factors restraining the global autologous matrix-induced chondrogenesis market growth. There are various health insurance firms don’t insure the procedure of AMIC. For instance, as per Blue Cross Blue Shield of North Carolina, in 2019, in the U.S, a complete hip replacement for patients with no health insurance, typically costs from US$ 31,839 to US$ 44,816, with the average expense being US$ 39,299.
Global Autologous Matrix-induced Chondrogenesis Market: Regional Analysis
Based on region, the global autologous matrix-induced chondrogenesis market is divided into North America, Europe, Latin America, Asia Pacific, Africa and Middle East. North America is expected to gain the highest share in the global autologous matrix-induced chondrogenesis market over the forecast period, due to increasing prevalence of injuries related to sports and increasing population. For instance, in 2017, as per the report from National Safety Council (NSC), the U.S. reported above 526,000 injuries related to sports.
Asia Pacific is expected to witness notable growth during the forecast period, due to rising minimally-invasive surgery demand in the area. For instance, in 2017, as per the National Center for Biotechnology Information (NCBI), the minimally-invasive surgery initially was executed in China. Amongst the first minimally-invasive surgery types was Laparoscopy surgery.
Global Autologous Matrix-induced Chondrogenesis Market: Competitive Landscape
Major players functioning in the global autologous matrix-induced chondrogenesis market are Biotissue AG, JRL Orthopaedic Ltd, Arthro-Kinetics, B Braun, Matricel GmbH, Melsungen AG, Zimmer Biomet Holdings and Geistlich Pharma AG.
Special Requirements?
We value your investment and offer customization as per your requirements.
Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/2748
Global Autologous Matrix-induced Chondrogenesis Market: Taxonomy
The global autologous matrix-induced chondrogenesis market is divided based on application, material type, and region.
On The Basis of Material Type:
- Hyaluronic Acid
- Polylactic-Co-Glycolic Acid
- Polyethylene Glycol
- Collagen
On The Basis of Application:
- Hip Cartilage
- Elbow Cartilage
- Knee Cartilage
On The Basis of Region:
- North America
- Europe
- Latin America
- Asia Pacific
- Africa
- Middle East
Other Exclusive Reports:
Angioedema Treatment Market Analysis
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
Editor Details
-
Company:
- Coherent Market Insights
-
Name:
- Nirav Gokani
- Email:
-
Telephone:
- +918849480752
- Website:
